Middlebrook

TXN Systems

This pharmaceutical company develops a novel class of antibiotics to treat multidrug-resistant urinary tract infections in patients.

Melinta Therapeutics

This biopharmaceutical company develops and commercialises antibiotics and antifungals to treat drug-resistant infections in hospital and clinic settings.

Amprologix

This biotechnology company develops novel antibiotics to treat antimicrobial-resistant bacterial infections for patients with conditions including MRSA and related skin and wound infections.

Paratek Pharmaceuticals

This company develops and commercialises antibiotics and nasal sprays for patients with infectious diseases, pneumonia, skin infections and chronic rhinosinusitis.

Peninsula Pharmaceuticals

The company develops and commercialises broad-spectrum antibiotics to treat patients with life-threatening infections, including hospital-acquired pneumonia and urinary tract infections.

Abgentis

This company develops broad-spectrum antibacterial drugs for pharmaceutical firms to treat acute, chronic, and drug-resistant infections.

Paratek

This company develops and supplies antibiotics and specialty medicines for healthcare providers treating serious infectious diseases and osteoporosis.

Infex Therapeutics

The company develops and licences antibacterial and antiviral drugs for pharmaceutical partners and healthcare providers to treat life-threatening infections and antimicrobial resistance.